The determination of blood fibrinolytic activity by synthetic chromogenic substrate S-2251 in patients with high risk of thromboembolism.
D005260:Female; D005342:Fibrinolysis; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000097:blood; D008297:Male; D008946:Mitral Valve Stenosis / Q000097:blood; D009203:Myocardial Infarction / Q000097:blood; D009842:Oligopeptides; D012306:Risk; D013923:Thromboembolism / Q000175:diagnosis*
D009842:Oligopeptides; C018788:valyl-leucyl-lysine 4-nitroanilide